Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Bupivacaine 0.25% Injectable Solution.
- Who it may be relevant to
- Registry conditions: Pain, Postoperative Pain. Basic parameters: 18 years — 50 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Cesarean section is one of the most common major surgical procedures performed worldwide,, Post-cesarean analgesia should provide adequate pain control while allowing the mother to remain active to meet the needs of the baby. Insufficient analgesia after cesarean section may be associated with acute postoperative pain, chronic pain, higher opioid consumption, delayed functional capacity, and postpartum depression. Techniques such as neuraxial techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to evaluate analgesic consumption.
Interventions
- Drug Bupivacaine 0.25% Injectable Solution
Ultrasound-guided block with 20 ml %0.25 bupivacaine, per side
Primary outcome measures
- Opioid Consumption [Time frame: Postoperative first 24 hours]
Secondary outcome measures (1)
- Visual Analog Pain Score [Time frame: Postoperative first 24 hours]
Eligibility criteria
Inclusion criteria
- Between 18-50 years
- Cesarean Section
Exclusion criteria
- Cesarean Section under general anesthesia
- emergency cases
- those with a body mass index greater than 35 kg/m2
- coagulopathy
- local infection
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 2 centers
- Erzurum Regional Training and Research Hospital — Erzurum
- Erzurum Regional Training and Research Hospital — Erzurum
Identifiers
NCT: NCT05117307 · TFP vs ESP on C/S